Skip to main content
SpringerLink
Log in

Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Summary: Gaucher disease, the most common sphingolipidosis, is caused by a decreased activity of glucosylceramide β-glucosidase, resulting in the accumulation of glucosylceramide in macrophage-derived cells known as Gaucher cells. Much of the storage material is thought to originate from the turnover of cell membranes, such as phagocytosed red and white blood cells. In this study, an in vitro model of Gaucher disease was developed by treating the murine macrophage cell line J774 with a specific inhibitor of glucosylceramide β-glucosidase, conduritol B-epoxide, and feeding red blood cell ghosts, in order to mimic the disease state. It was found in this model system that glucosylceramide β-glucosidase activity could be reduced to about 11–15! of the normal control level before increased storage of glucosylceramide occurred. This in vitro system allows insight into the correlation between enzyme activity and lipid storage as predicted by the theory of residual enzyme activity that was proposed by Conzelmann and Sandhoff.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Brady RO, Kanfer JN, Shapiro D (1965)Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Commun 18: 221–225.

    Google Scholar 

  • Brady RO, Pentchev PG, Gal AE, Hibbert SR, Dekaban AS (1974) Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease. N Engl J Med 291: 989–993.

    Google Scholar 

  • Coleman PL, Fishman PH, Brady RO, Todaro GJ (1975) Altered ganglioside biosynthesis in mouse cell cultures following transformation with chemical carcinogens and x-irradiation. J Biol Chem 250: 55–60.

    Google Scholar 

  • Conzelmann E, Sandhoff K (1983) Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev Neurosci 6: 58–71.

    Google Scholar 

  • Cox T, Lachmann R, Hollak C, et al (2000) Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 355: 1481–1485.

    Google Scholar 

  • Das PK, Murray GJ, Gal AE, Barranger JA (1987) Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages. Exp Cell Res 168: 463–474.

    Google Scholar 

  • Desnick RJ, Schuchman EH (2002) Enzyme replacement and enhancement therapies: lessons from lysosomal disorders. Nat Rev Genet 3: 954–966.

    Google Scholar 

  • Fishman PH, Brady RO, Bradley RM, Aaronson SA, Todaro GJ (1974) Absence of a specific ganglioside galactosyltransferase in mouse cells transformed by murine sarcoma virus. Proc Natl Acad Sci USA 71: 298–301.

    Google Scholar 

  • Hakomori SI, Murakami WT (1968) Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines. Proc Natl Acad Sci USA 59: 254–261.

    Google Scholar 

  • Kanfer JN, Legler G, Sullivan J, Raghavan SS, Mumford RA (1975) The Gaucher mouse. Biochem Biophys Res Commun 67: 85–90.

    Google Scholar 

  • Kattlove HE, Williams JC, Gaynor E, Spivack M, Bradley RM, Brady RO (1969) Gaucher cells in chronic myelocytic leukemia: an acquired abnormality. Blood 33: 379–390.

    Google Scholar 

  • Kolter T, Sandhoff K (1998) Recent advances in the biochemistry of sphingolipidoses. Brain Pathol 8: 79–100.

    Google Scholar 

  • Kolter T, Sandhoff K (1999) Angew Chem Int Ed 38: 1532–1568.

    Google Scholar 

  • Lee RE (1968) The fine structure of the cerebroside occurring in Gaucher's disease. Proc Natl Acad Sci USA 61: 484–489.

    Google Scholar 

  • Leinekugel P, Michel S, Conzelmann E, Sandhoff K (1992) Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88: 513–523.

    Google Scholar 

  • Miller SP, Zirzow GC, Doppelt SH, Brady RO, Barton NW (1996) Analysis of the lipids of normal and Gaucher bone marrow. J Lab Clin Med 127: 353–358.

    Google Scholar 

  • Mora PT, Brady RO, Bradley RM, McFarland VW (1969) Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines. Proc Natl Acad Sci USA 63: 1290–1296.

    Google Scholar 

  • Newburg DS, Yatziv S, McCluer RH, Raghavan S (1986) beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell. Biochim Biophys Acta 877: 121–126.

    Google Scholar 

  • Newburg DS, Shea TB, Yatziv S, Raghavan SS, McCluer RH (1988) Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells. Exp Mol Pathol 48: 317–323.

    Google Scholar 

  • Patrick AD (1965) Short communications: a deficiency of glucocerebrosidase in Gaucher's disease. Biochem J 97: 17C–18C.

    Google Scholar 

  • Radin NS (1982) Inhibitors and stimulators of glucocerebroside metabolism. Prog Clin Biol Res 95: 357–383.

    Google Scholar 

  • Sandhoff K, Kolter T (1996) Trends Cell Biol 6: 98–103.

    Google Scholar 

  • Sandhoff K, Kolter T (2003) Biosynthesis and degradation of mammalian glycosphingolipids.Phil Trans R Soc Lond B Biol Sci 358: 847–861.

    Google Scholar 

  • Sawkar A, Cheng W, Beutler E, Wong C, Balch W, Kelly J (2002) Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease Proc Natl Acad Sci USA 99: 15428–15433.

    Google Scholar 

  • Smith PK, Krohn RI, Hermanson GT, et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85.

    Google Scholar 

  • Stephens MC, Bernatsky A, Burachinsky V, Legler G, Kanfer JN (1978) The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects. J Neurochem 30: 1023–1027.

    Google Scholar 

  • Stephens MC, Bernatsky A, Legler G, Kanfer JN (1979) The Gaucher mouse: additional biochemical alterations. J Neurochem 32: 969–972.

    Google Scholar 

  • Suzuki K (1978) Enzymic diagnosis of sphingolipidoses. Methods Enzymol 50: 456–488.

    Google Scholar 

  • Ullman MD, McCluer RH (1977) Quantitative analysis of plasma neutral glycosphingolipids by high performance liquid chromatography of their perbenzoyl derivatives. J Lipid Res 18: 371–378.

    Google Scholar 

  • van Echten G, Sandhoff K (1989) Modulation of ganglioside biosynthesis in primary cultured neurons. J Neurochem 52: 207–214.

    Google Scholar 

  • von der Heul C, Kroos MJ, de Jeu-Jaspars CM, von Eijk HG (1980) The uptake of iron by reticulocytes. The in£uence of purification of the ghosts on iron-containing components in the ghost suspension. Biochim Biophys Acta 601: 572–583.

    Google Scholar 

  • Walkley SU (1998) Cellular pathology of lysosomal storage disorders. Brain Pathol 8: 175–193.

    Google Scholar 

  • Wilkening G, Linke T, Sandhoff K (1998) Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J Biol Chem 273: 30271–30278.

    Google Scholar 

  • Yatziv S, Newburg DS, Livni N, Barfi G, Kolodny EH (1988) Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition. J Lab Clin Med 111: 416–420.

    Google Scholar 

  • Zhao H, Grabowski GA (2002) Gaucher disease: perspectives on a prototype lysosomal disease. Cell Mol Life Sci 59: 694–707.

    Google Scholar 

Download references

Author information

Author notes

  1. U. H. Schueler

    Present address: Kekulé-Institut für Organische Chemie und Biochemie der Universität Bonn, Gerhard-Domagk-Str. 1, D-53121, Bonn, Germany

Authors and Affiliations

  1. Developmental and Metabolic Neurology Branch, NINDS, NIH, Bethesda, Maryland, USA

    U. H. Schueler, C. R. Kaneski, G. C. Zirzow & R. O. Brady

  2. Kekulé-Institut für Organische Chemie und Biochemie der Universität Bonn, Bonn, Germany

    U. H. Schueler, T. Kolter & K. Sandhoff

Authors
  1. U. H. Schueler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Kolter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. R. Kaneski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. C. Zirzow
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Sandhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. O. Brady
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schueler, U.H., Kolter, T., Kaneski, C.R. et al. Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease. J Inherit Metab Dis 27, 649–658 (2004). https://doi.org/10.1023/B:BOLI.0000042959.44318.7c

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BOLI.0000042959.44318.7c

Keywords

Search

Navigation